Skip to content

Clinical trials

Lung Neoplasms trials in the Netherlands with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Unknown status Country / region: Netherlands Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20131
20151
20161
20191
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Commissie Voor Klinisch Toegepast Onderzoek1
Frisius Medisch Centrum1
Isala1
Maastricht University1
National Cancer Institute (NCI)1
Radboud University Medical Center1
Universitaire Ziekenhuizen KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms10
Adenoma, Islet Cell1
Carcinoma, Non-Small-Cell Lung1
Gastrinoma1
Glucagonoma1
Insulinoma1
Leukemia1
Leukemia, Myeloid, Acute1
Neoplasm Metastasis1
Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.